Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2021

Open Access 01-12-2021 | Pancreatitis | Research article

Correlation between PCT, 25(OH)D, PTX-3, AMS levels and the severity of diabetic ketoacidosis complicated by pancreatitis

Authors: Songtao Lu, Dongmei Wei, Chao Yin, Juwen Xiong, Lishuang Zhu, Shaoru Yan, Rui Meng

Published in: BMC Endocrine Disorders | Issue 1/2021

Login to get access

Abstract

Background

This study aims to explore the correlation between procalcitonin (PCT), 25-hydroxyvitamin D3 (25(OH)D), pentraxin-3 (PTX-3), amylase (AMS) levels and severity of diabetic ketoacidosis complicated by pancreatitis.

Methods

A retrospective analysis of 198 patients with diabetic ketoacidosis admitted to our hospital from January 2015 to February 2020 were included. According to whether the patients with pancreatitis, subjects were divided into diabetic ketoacidosis with pancreatitis (DKA-AP) group and diabetic ketoacidosis (DKA) group. Healthy controls admitted to the hospital for physical examinations were included as a control group. Clinical outcomes were collected.

Results

On the first day after admission, the levels of PCT, PTX-3, and AMS in DKA-AP group were significantly higher than those in DKA group and control group, and 25(OH)D levels in DKA-AP group were lower than those in DKA group and control group. PCT, PTX-3, and AMS levels were significantly increased, and 25(OH)D levels were decreased in the DKA group compared with the control group. Furthermore, the levels of PCT, 25(OH)D, PTX-3, and AMS in the DKA-AP group were correlated with the disease severity of of diabetic ketoacidosis complicated by pancreatitis. The levels of PCT, PTX-3, and AMS in the DKA-AP group on day 1 were significantly higher and 25(OH)D levels were significantly lower than those on days 3–7 after admission. The levels of PCT, PTX-3, and AMS in the DKA group on day 1 were significantly higher and 25(OH)D levels were significantly lower than those on days 2–7 after admission. The levels of these indicators returned to normal levels on day 3 or day 7 in DKA or DKA-AP group, respectively. PCT, PTX-3, and AMS levels in the DKA-AP group were significantly increased, while 25(OH)D levels in the DKA-AP group were decreased compared with DKA group on days 1–6 after admission. The duration of hospital stay, patients of ICU care, duration of ICU stay, and cost in DKA-AP group were all higher than those in the DKA group.

Conclusion

Blood levels of PCT, 25(OH)D, PTX-3, and AMS were correlated with diabetic ketoacidosis complicated by pancreatitis, and have certain application value in assessment of the disease severity.
Literature
1.
go back to reference Modi A, Agrawal A, Morgan F. Euglycemic diabetic ketoacidosis: a review. Curr Diabetes Rev. 2017;13(3):315–21.CrossRef Modi A, Agrawal A, Morgan F. Euglycemic diabetic ketoacidosis: a review. Curr Diabetes Rev. 2017;13(3):315–21.CrossRef
2.
go back to reference Cashen K, Petersen T. Diabetic Ketoacidosis. Pediatr Rev. 2019;40(8):412–20.CrossRef Cashen K, Petersen T. Diabetic Ketoacidosis. Pediatr Rev. 2019;40(8):412–20.CrossRef
3.
go back to reference Wang XJ, Zhu CY, Lin JC. The characteristics of amylase levels in patients with diabetic ketoacidosis complicated by acute pancreatitis. Chin J Clin. 2015;9(05):847–9. Wang XJ, Zhu CY, Lin JC. The characteristics of amylase levels in patients with diabetic ketoacidosis complicated by acute pancreatitis. Chin J Clin. 2015;9(05):847–9.
4.
go back to reference Wang YQ, Tian H, Zhang XM, et al. Th role of serum PTX-3 in patients with acute pancreatitis [J]. Heilongjiang Med Pharm. 2019;42(03):19–20. Wang YQ, Tian H, Zhang XM, et al. Th role of serum PTX-3 in patients with acute pancreatitis [J]. Heilongjiang Med Pharm. 2019;42(03):19–20.
5.
go back to reference Expert consensus group of clinical application of procalcitonin in emergency medicine. Expert consensus on clinical application of procalcitonin (PCT) in emergency medicine. Chin J Emerg Med. 2012;21(9):944–51. Expert consensus group of clinical application of procalcitonin in emergency medicine. Expert consensus on clinical application of procalcitonin (PCT) in emergency medicine. Chin J Emerg Med. 2012;21(9):944–51.
6.
go back to reference Li J, Jiang X, Ma HY. Value of procalcitonin in prediction of infection of diabetic ketodcidosis patients and the changes of procalcitonin level. Chin Gen Pract. 2016;19(26):3165–9. Li J, Jiang X, Ma HY. Value of procalcitonin in prediction of infection of diabetic ketodcidosis patients and the changes of procalcitonin level. Chin Gen Pract. 2016;19(26):3165–9.
7.
go back to reference Al-Zubeidi H, Leon-Chi L, Newfield RS. Low vitamin D level in pediatric patients with new onset type 1 diabetes is common, especially if in ketoacidosis. Pediatr Diabetes. 2016;17(8):592–8.CrossRef Al-Zubeidi H, Leon-Chi L, Newfield RS. Low vitamin D level in pediatric patients with new onset type 1 diabetes is common, especially if in ketoacidosis. Pediatr Diabetes. 2016;17(8):592–8.CrossRef
8.
go back to reference Feng SQ, Wei QQ, Meng WP, et al. Serum 25-hydroxyvitamin D level and its relation with prognosis in patients with moderate-to-severe acute pancreatitis. Guangxi Med J. 2019;41(07):832–5. Feng SQ, Wei QQ, Meng WP, et al. Serum 25-hydroxyvitamin D level and its relation with prognosis in patients with moderate-to-severe acute pancreatitis. Guangxi Med J. 2019;41(07):832–5.
9.
go back to reference Cuello F, Shankar-Hari M, Mayr U, et al. Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis. Mol Cell Proteomics. 2014;13(10):2545–57.CrossRef Cuello F, Shankar-Hari M, Mayr U, et al. Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis. Mol Cell Proteomics. 2014;13(10):2545–57.CrossRef
10.
go back to reference Meryk P, Dumnicka P, Kuśnierz-Cabala B, et al. Znaczenie pentraksyn we wczesnejdiagnostyce ostrego zapalenia trzustki [diagnostic importance of pentraxins at the early phase of acute pancreatitis]. Przegl Lek. 2014;71(6):309–13.PubMed Meryk P, Dumnicka P, Kuśnierz-Cabala B, et al. Znaczenie pentraksyn we wczesnejdiagnostyce ostrego zapalenia trzustki [diagnostic importance of pentraxins at the early phase of acute pancreatitis]. Przegl Lek. 2014;71(6):309–13.PubMed
11.
go back to reference Zhong F, Zhong BB. Correlation between serum amylase, myocardial enzymes, and severity of diabetic ketoacidosis [J]. Mod Instrum Med Treat. 2018;024(002):76–7. Zhong F, Zhong BB. Correlation between serum amylase, myocardial enzymes, and severity of diabetic ketoacidosis [J]. Mod Instrum Med Treat. 2018;024(002):76–7.
12.
go back to reference American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-018. Diabetes Care. 2018;41(Suppl 1):S13–27.CrossRef American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-018. Diabetes Care. 2018;41(Suppl 1):S13–27.CrossRef
13.
go back to reference Wolfsdorf JI, Allgrove J, Craig ME, et al. ISPAD clinical practice consensus guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15(Suppl 20):S154–79.CrossRef Wolfsdorf JI, Allgrove J, Craig ME, et al. ISPAD clinical practice consensus guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15(Suppl 20):S154–79.CrossRef
14.
go back to reference Wang YJ, Li HL, Xu BH, et al. The role of serum procalcitonin, C-reactive protein and endotoxin in pancreatitis patient. Shandong Med J. 2018;058(013):48–50. Wang YJ, Li HL, Xu BH, et al. The role of serum procalcitonin, C-reactive protein and endotoxin in pancreatitis patient. Shandong Med J. 2018;058(013):48–50.
15.
go back to reference Blanchard F, Charbit J, Van der Meersch G, et al. Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis. Ann Intensive Care. 2020;10(1):1–10.CrossRef Blanchard F, Charbit J, Van der Meersch G, et al. Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis. Ann Intensive Care. 2020;10(1):1–10.CrossRef
16.
go back to reference Gupta AK, Brashear MM, Johnson WD. Low vitamin D levels, prediabetes and prehypertension in healthy African American adults. Nutr Metab Cardiovasc Dis. 2012;22(10):877–82.CrossRef Gupta AK, Brashear MM, Johnson WD. Low vitamin D levels, prediabetes and prehypertension in healthy African American adults. Nutr Metab Cardiovasc Dis. 2012;22(10):877–82.CrossRef
17.
go back to reference Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–8.CrossRef Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–8.CrossRef
18.
go back to reference Liu B, Hong X. Relationship of serum 25-hydroxyvitamin D level with glycemic control and ketoacidosis in patients with newly onset type 2 diabetes mellitus. J Chin Pract Diagn Ther. 2018;32(05):480–2. Liu B, Hong X. Relationship of serum 25-hydroxyvitamin D level with glycemic control and ketoacidosis in patients with newly onset type 2 diabetes mellitus. J Chin Pract Diagn Ther. 2018;32(05):480–2.
19.
go back to reference Xu HQ. Clinical value of CRP, GLU, TG and AMS in the diagnosis of acute pancreatitis. J Trop Med. 2016;16(010):1251–3. Xu HQ. Clinical value of CRP, GLU, TG and AMS in the diagnosis of acute pancreatitis. J Trop Med. 2016;16(010):1251–3.
Metadata
Title
Correlation between PCT, 25(OH)D, PTX-3, AMS levels and the severity of diabetic ketoacidosis complicated by pancreatitis
Authors
Songtao Lu
Dongmei Wei
Chao Yin
Juwen Xiong
Lishuang Zhu
Shaoru Yan
Rui Meng
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2021
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-021-00792-9

Other articles of this Issue 1/2021

BMC Endocrine Disorders 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.